BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang J, Zhao M, Chang C, Wu H, Lu Q. Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases. Clin Rev Allergy Immunol 2020;59:248-72. [PMID: 32557263 DOI: 10.1007/s12016-020-08798-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Redmond MT, Scherzer R, Prince BT. Novel Genetic Discoveries in Primary Immunodeficiency Disorders. Clin Rev Allergy Immunol 2022. [PMID: 35020168 DOI: 10.1007/s12016-021-08881-2] [Reference Citation Analysis]
2 Mancini M, Charbonneau B, Langlais D, Vidal SM. The c-Rel transcription factor limits early interferon and neuroinflammatory responses to prevent herpes simplex encephalitis onset in mice. Sci Rep 2021;11:21171. [PMID: 34707143 DOI: 10.1038/s41598-021-00391-7] [Reference Citation Analysis]
3 Wang C, Zhou W, Liu Y, Xu Y, Zhang X, Jiang C, Jiang M, Cao X. Nuclear translocation of RIG-I promotes cellular apoptosis. Journal of Autoimmunity 2022;130:102840. [DOI: 10.1016/j.jaut.2022.102840] [Reference Citation Analysis]
4 Zhao M, Wang Z, Yang M, Ding Y, Zhao M, Wu H, Zhang Y, Lu Q. The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases. Clin Rev Allergy Immunol 2021;60:220-43. [PMID: 33411320 DOI: 10.1007/s12016-020-08829-y] [Reference Citation Analysis]
5 Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. Effects of statins on myocarditis: A review of underlying molecular mechanisms. Prog Cardiovasc Dis 2021;67:53-64. [PMID: 33621589 DOI: 10.1016/j.pcad.2021.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Musella M, Galassi C, Manduca N, Sistigu A. The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation. Biology (Basel) 2021;10:856. [PMID: 34571733 DOI: 10.3390/biology10090856] [Reference Citation Analysis]
7 Tonutti A, Motta F, Ceribelli A, Isailovic N, Selmi C, De Santis M. Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review. Front Immunol 2022;13:937667. [DOI: 10.3389/fimmu.2022.937667] [Reference Citation Analysis]
8 Zhang M, Dai R, Zhao Q, Zhou L, An Y, Tang X, Zhao X. Identification of Key Biomarkers and Immune Infiltration in Systemic Juvenile Idiopathic Arthritis by Integrated Bioinformatic Analysis. Front Mol Biosci 2021;8:681526. [PMID: 34336925 DOI: 10.3389/fmolb.2021.681526] [Reference Citation Analysis]
9 Papadopoulos VE, Skarlis C, Evangelopoulos ME, Mavragani CP. Type I interferon detection in autoimmune diseases: challenges and clinical applications. Expert Rev Clin Immunol 2021;17:883-903. [PMID: 34096436 DOI: 10.1080/1744666X.2021.1939686] [Reference Citation Analysis]
10 Hu Y, Chen B, Yang F, Su Y, Yang D, Yao Y, Wang S, Wu Y, Tao L, Xu T. Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection. Autoimmun Rev 2022;:103155. [PMID: 35902046 DOI: 10.1016/j.autrev.2022.103155] [Reference Citation Analysis]
11 Aylan Gelen S, Kara B, Eser Şimsek I, Güngör M, Zengin E, Sarper N. Autoimmune Hemolytic Anemia Due to Spondyloenchondrodysplasia with Spastic Paraparesis and Intracranial Calcification due to Mutation in ACP5. J Pediatr Genet. [DOI: 10.1055/s-0041-1736560] [Reference Citation Analysis]
12 Kazakov AS, Sofin AD, Avkhacheva NV, Denesyuk AI, Deryusheva EI, Rastrygina VA, Sokolov AS, Permyakova ME, Litus EA, Uversky VN, Permyakov EA, Permyakov SE. Interferon Beta Activity Is Modulated via Binding of Specific S100 Proteins. Int J Mol Sci 2020;21:E9473. [PMID: 33322098 DOI: 10.3390/ijms21249473] [Reference Citation Analysis]
13 Li Y, Bax C, Patel J, Vazquez T, Ravishankar A, Bashir MM, Grinnell M, Diaz D, Werth VP. Plasma-derived DNA containing-extracellular vesicles induce STING-mediated proinflammatory responses in dermatomyositis. Theranostics 2021;11:7144-58. [PMID: 34158841 DOI: 10.7150/thno.59152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
14 Allred MG, Chimenti MS, Ciecko AE, Chen YG, Lieberman SM. Characterization of Type I Interferon-Associated Chemokines and Cytokines in Lacrimal Glands of Nonobese Diabetic Mice. Int J Mol Sci 2021;22:3767. [PMID: 33916486 DOI: 10.3390/ijms22073767] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Park YJ, Kang BH, Kim HJ, Oh JE, Lee HK. A Microbiota-Dependent Subset of Skin Macrophages Protects Against Cutaneous Bacterial Infection. Front Immunol 2022;13:799598. [PMID: 35757750 DOI: 10.3389/fimmu.2022.799598] [Reference Citation Analysis]
16 Hu H, Yang H, Liu Y, Yan B. Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System. Front Med 2022;8:833114. [DOI: 10.3389/fmed.2021.833114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chasset F, Dayer JM, Chizzolini C. Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment. Front Pharmacol 2021;12:633821. [PMID: 33986670 DOI: 10.3389/fphar.2021.633821] [Reference Citation Analysis]
18 Mazewski C, Perez RE, Fish EN, Platanias LC. Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways. Front Immunol 2020;11:606456. [PMID: 33329603 DOI: 10.3389/fimmu.2020.606456] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
19 Sur D, Leonova K, Levi B, Markowitz SI, Cohen-harazi R, Gitlin I, Gurova K, Gudkov A, Pinhasov A, Koman I, Nesher E. Targeted Modulation of Interferon Response-Related Genes with IFN-Alpha/Lambda Inhibition. IJMS 2022;23:7248. [DOI: 10.3390/ijms23137248] [Reference Citation Analysis]
20 Cai S, Hu Z, Chen Y, Zhong J, Dong L. Potential roles of non-lymphocytic cells in the pathogenesis of IgG4-related disease. Front Immunol 2022;13:940581. [DOI: 10.3389/fimmu.2022.940581] [Reference Citation Analysis]
21 Duguet F, Ortega-Ferreira C, Fould B, Darville H, Berger S, Chomel A, Leclerc G, Kisand K, Haljasmägi L, Hayday AC, Desvaux E, Nony E, Moingeon P, De Ceuninck F. S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases. J Transl Autoimmun 2021;4:100093. [PMID: 33748735 DOI: 10.1016/j.jtauto.2021.100093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Huang Y, Liang W, Li K, Liao X, Chen J, Qiu X, Liu K, Qiu D, Qin Y. Sorafenib suppresses the activation of type I interferon pathway induced by RLR-MAVS and cGAS-STING signaling. Biochemical and Biophysical Research Communications 2022;623:181-8. [DOI: 10.1016/j.bbrc.2022.07.028] [Reference Citation Analysis]
23 Zeng Z, Wang Y, Xiao Y, Zheng J, Liu R, He X, Yu J, Tang B, Qiu X, Tang R, Shi Y, Xiao R. Overexpression of OASL upregulates TET1 to induce aberrant activation of CD4+ T cells in systemic sclerosis via IRF1 signaling. Arthritis Res Ther 2022;24. [DOI: 10.1186/s13075-022-02741-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Moon J, Yoon CH, Choi SH, Kim MK. Can Gut Microbiota Affect Dry Eye Syndrome? Int J Mol Sci 2020;21:E8443. [PMID: 33182758 DOI: 10.3390/ijms21228443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Liu Y, Xiao J, Qiao G, Wang Q, Yang X, Xu X, Li J, Zhang J, Chang M, Feng H. DDX19 inhibits RLR/IRF3 mediated type I interferon signaling of black carp Mylopharyngodon piceus by restricting IRF3 from entering nucleus. Aquaculture 2022;553:738087. [DOI: 10.1016/j.aquaculture.2022.738087] [Reference Citation Analysis]
26 Li X, Shao M, Zeng X, Qian P, Huang H. Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy. Signal Transduct Target Ther 2021;6:367. [PMID: 34667157 DOI: 10.1038/s41392-021-00764-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kotyla PJ, Islam MA, Engelmann M. Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis. Int J Mol Sci 2020;21:E7390. [PMID: 33036382 DOI: 10.3390/ijms21197390] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Tucci G, Garufi C, Pacella I, Zagaglioni M, Pinzon Grimaldos A, Ceccarelli F, Conti F, Spinelli FR, Piconese S. Baricitinib therapy response in rheumatoid arthritis patients associates to STAT1 phosphorylation in monocytes. Front Immunol 2022;13:932240. [DOI: 10.3389/fimmu.2022.932240] [Reference Citation Analysis]
29 Barnas JL, Albrecht J, Meednu N, Alzamareh DF, Baker C, McDavid A, Looney RJ, Anolik JH. B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-λ in Systemic Lupus Erythematosus. J Immunol 2021;207:2660-72. [PMID: 34706932 DOI: 10.4049/jimmunol.2100339] [Reference Citation Analysis]
30 Guo M, Cao W, Chen S, Tian R, Wang L, Liu Q, Zhang L, Wang Z, Zhao M, Lu Q, Zhu H. TRIM10 binds to IFN-α/β receptor 1 to negatively regulate type I IFN signal transduction. Eur J Immunol 2021;51:1762-73. [PMID: 33811647 DOI: 10.1002/eji.202049073] [Reference Citation Analysis]
31 Lepelley A, Wai T, Crow YJ. Mitochondrial Nucleic Acid as a Driver of Pathogenic Type I Interferon Induction in Mendelian Disease. Front Immunol 2021;12:729763. [PMID: 34512665 DOI: 10.3389/fimmu.2021.729763] [Reference Citation Analysis]
32 Brady MP, Chava S, Tandon S, Rane MJ, Barati MT, Caster DJ, Powell DW. Serum and Urine Interferon Gamma-Induced Protein 10 (IP-10) Levels in Lupus Nephritis. J Clin Med 2022;11:3199. [PMID: 35683585 DOI: 10.3390/jcm11113199] [Reference Citation Analysis]